What is the treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

The first-line treatment for bacterial conjunctivitis is topical antibiotic therapy, with broad-spectrum options including ciprofloxacin, polymyxin B-bacitracin, trimethoprim-polymyxin B, gentamicin, tetracycline, or ofloxacin for a standard course of 5-7 days. 1

Clinical Presentation and Diagnosis

Bacterial conjunctivitis typically presents with:

  • Purulent or mucopurulent discharge
  • Matting of eyelids (especially upon waking)
  • Conjunctival injection (redness)
  • Mild discomfort or foreign body sensation
  • Absence of significant pain or vision loss 1

Common causative organisms include:

  • Haemophilus influenzae
  • Streptococcus pneumoniae
  • Staphylococcus aureus
  • Staphylococcus epidermidis
  • Moraxella species 1, 2

Treatment Algorithm

Standard Cases

  1. First-line treatment options:

    • Topical gentamicin
    • Topical tetracycline
    • Topical ofloxacin
    • Ciprofloxacin
    • Polymyxin B-bacitracin
    • Trimethoprim-polymyxin B 1
  2. Newer fluoroquinolone option:

    • Gatifloxacin 0.5% ophthalmic solution: One drop every two hours while awake (up to 8 times) on Day 1, then one drop 2-4 times daily on Days 2-7 3
    • Moxifloxacin 0.5% ophthalmic solution: Effective against common pathogens including S. aureus, S. epidermidis, S. pneumoniae, and H. influenzae 1
  3. Duration of treatment:

    • Standard course: 5-7 days
    • Continue until:
      • Resolution of discharge
      • No more matting of eyelids in the morning
      • Reduction in conjunctival injection 1

Special Cases

  1. Gonococcal conjunctivitis:

    • BOTH systemic and topical therapy required
    • Systemic: Ceftriaxone (single dose)
    • Plus topical antibiotic therapy 1
  2. Chlamydial conjunctivitis:

    • Systemic therapy with one of:
      • Azithromycin (1g orally, single dose) OR
      • Doxycycline (100mg orally twice daily for 7 days) OR
      • Levofloxacin (500mg orally once daily for 7 days) 1
  3. Neonatal conjunctivitis:

    • Requires prompt evaluation and treatment based on timing:
      • 1-7 days after birth: Consider gonococcal infection
      • 5-19 days: Consider chlamydial infection
      • First week: Common bacterial infection (S. aureus, Enterococcus, Klebsiella, E. coli) 1

Considerations for Antibiotic Selection

  • Fluoroquinolones like gatifloxacin and moxifloxacin offer broad-spectrum coverage and excellent tissue penetration 4
  • Gatifloxacin 0.5% is FDA-approved for bacterial conjunctivitis caused by:
    • S. aureus, S. epidermidis, S. pneumoniae (gram-positive)
    • H. influenzae (gram-negative) 3
  • Increasing resistance to fluoroquinolones has been reported, particularly in MRSA isolates 1
  • Delayed antibiotic prescribing may be considered for mild cases 1, 5

Prevention and Infection Control

  • Frequent handwashing
  • Avoid sharing towels and pillowcases
  • Proper disinfection of surfaces
  • Patients with bacterial conjunctivitis can typically return to work or school after 24 hours of antibiotic treatment 1

When to Refer to Ophthalmology

Refer if:

  • No response to therapy after 3-4 days
  • Moderate to severe pain
  • Decreased vision
  • Corneal involvement
  • Conjunctival scarring
  • Recurrent episodes
  • History of herpes simplex virus eye disease
  • Immunocompromised patients 1, 5

Important Caveats

  • Indiscriminate use of antibiotics should be avoided as mild bacterial conjunctivitis is often self-limiting 1, 6
  • Contact lens wearers should discontinue lens wear during treatment 3
  • Patients should be advised not to wear contact lenses if they have signs and symptoms of bacterial conjunctivitis 3
  • Prolonged use of antibiotics may result in overgrowth of nonsusceptible organisms, including fungi 3

References

Guideline

Ocular Infections and Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.